Feng LS - Search Results

1

Diagnosis and treatment of insulinoma: report of 105 cases.

Feng LS, Ma XX, Tang Z, Zhao YF, Ye XX, Xu PQ. Feng LS, et al. Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):137-9. Hepatobiliary Pancreat Dis Int. 2002. PMID: 14607643

2

Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experience.

Xu PQ, Ma XX, Ye XX, Feng LS, Dang XW, Zhao YF, Zhang SJ, Zhao LS, Tang Z, Lu XB. Xu PQ, et al. Among authors: feng ls. Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):391-4. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15313675

3

Management of severe Budd-Chiari syndrome: report of 147 cases.

Feng LS, Peng QP, Li K, Ma XX, Zhao YF, Ye XX, Xu PQ, Chen XP. Feng LS, et al. Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):522-5. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15567737

4

Triplex operation for portal hypertension with esophageal variceal bleeding: report of 140 cases.

Feng LS, Li K, Peng QP, Ma XX, Zhao YF, Xu PQ, Chen XP. Feng LS, et al. Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):534-7. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15567740

5

Combined splenocaval or mesocaval C shunt and portoazygous devascularization in the treatment of portal hypertension: analysis of 150 cases.

Feng LS, Chen XP. Feng LS, et al. Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):70-3. Hepatobiliary Pancreat Dis Int. 2006. PMID: 16481287

6

Breviscapine alleviates hepatic injury and inhibits PKC-mRNA and its protein expression in brain-dead BA-Ma mini pigs.

Zhang SJ, Song Y, Zhai WL, Shi JH, Feng LS, Zhao YF, Chen S. Zhang SJ, et al. Among authors: feng ls. Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):604-9. Hepatobiliary Pancreat Dis Int. 2007. PMID: 18086626

7

Necessity and indications of invasive treatment for Budd-Chiari syndrome.

Fu Y, Sun YL, Ma XX, Xu PQ, Feng LS, Tang Z, Guan S, Wang ZW, Luo CH. Fu Y, et al. Among authors: feng ls. Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):254-60. doi: 10.1016/s1499-3872(11)60042-8. Hepatobiliary Pancreat Dis Int. 2011. PMID: 21669567

8

Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.

Zhang S, Li G, Ma X, Wang Y, Liu G, Feng L, Zhao Y, Zhang G, Wu Y, Ye X, Qin B, Lu J. Zhang S, et al. Cell Signal. 2012 Sep;24(9):1803-9. doi: 10.1016/j.cellsig.2012.05.009. Epub 2012 May 17. Cell Signal. 2012. PMID: 22609455

9

[Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].

Wu Y, Li J, Zhang SJ, Zhao YF, Zhao LS, Ma XX, Feng LS, Fan ZJ. Wu Y, et al. Among authors: feng ls. Zhonghua Wai Ke Za Zhi. 2012 Aug;50(8):691-4. Zhonghua Wai Ke Za Zhi. 2012. PMID: 23157899 Clinical Trial. Chinese.

10

Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1.

Li G, Zhang S, Fang H, Yan B, Zhao Y, Feng L, Ma X, Ye X. Li G, et al. Biochem Biophys Res Commun. 2013 May 17;434(4):809-14. doi: 10.1016/j.bbrc.2013.04.018. Epub 2013 Apr 20. Biochem Biophys Res Commun. 2013. PMID: 23611778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters